Literature DB >> 19046781

Pigment epithelium-derived factor (PEDF) inhibits collagen-induced platelet activation by reducing intraplatelet nitrotyrosine levels.

Sho-ichi Yamagishi, Takanori Matsui, Kazuo Nakamura, Katsuhiko Takenaka.   

Abstract

We have recently found that pigment epithelium-derived factor (PEDF), a glycoprotein with a potent neuronal differentiating activity, not only inhibits platelet aggregation and P-selectin expression, but also suppresses occlusive thrombus formation in rats through its anti-oxidative properties. These findings suggest that PEDF may play a protective role against atherothrombosis. However, the underlying molecular mechanism by which PEDF inhibited platelet aggregation and activation in vitro is fully understood. Since nitric oxide (NO) suppresses platelet aggregation and activation, it is conceivable that PEDF could inhibit platelet activation by suppressing the inactivation of NO and subsequent formation of peroxynitrite via its anti-oxidative properties. In this study, we examined whether PEDF reduced intraplatelet nitrotyrosine levels, a marker of protein nitration by peroxynitrite, and subsequently suppressed platelet-derived growth factor-AB (PDGF-AB) production by collage-exposed platelets. PEDF was found to significantly reduce the collagen-elicited intraplatelet nitrotyrosine formation and PDGF-AB secretion by platelets. The present study demonstrated for the first time that PEDF could inhibit the collagen-induced platelet activation by suppressing nitrotyrosine formation. PEDF may inhibit the platelet activation by suppressing the inactivation of NO and subsequent formation of peroxynitrite via its anti-oxidative properties. Copyright 2008 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19046781     DOI: 10.1016/j.ijcard.2008.11.015

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  1 in total

1.  Anti-platelet effects of anti-glaucomatous eye drops: an in vitro study on human platelets.

Authors:  Marilita M Moschos; Giannis A Moustafa; Vasiliki D Papakonstantinou; Michael Tsatsos; Konstantinos Laios; Smaragdi Antonopoulou
Journal:  Drug Des Devel Ther       Date:  2017-04-19       Impact factor: 4.162

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.